The Ovarian Cancer Diagnostics Market was valued at USD 4.68 billion in 2023 and is projected to reach USD 7.28 billion by 2032, growing at a CAGR of 5.06% during the forecast period of 2024-2032. The increasing incidence of ovarian cancer, coupled with technological advancements in diagnostic methods, is driving market expansion. Innovations in imaging techniques, biomarker research,...